Quantum BioPharma Ltd. Dec 2024 Form 6-K: Key Insights & Compliance Overview

Here are the key insights extracted from the provided section of the financial report (Form 6-K) for Quantum BioPharma Ltd.:

1. Company Information:

• Name: Quantum BioPharma Ltd.
• Address: 55 University Ave., Suite 1003, Toronto, Ontario M5J 2H7, Canada.

2. Report Details:

• Type: Form 6-K (Report of Foreign Private Issuer).
• Commission File Number: 001-39152.
• Period Covered: Month of December 2024.
  

3. Signatures:

• The report is signed by Donal Carroll, who is the Chief Financial Officer of the company.
• Date of Signature: December 20, 2024.

4. Exhibit Index:

• The report includes an Exhibit 99.1, described as a "Press Release," which can be accessed via a provided link (fsd_ex991.htm).

5. Regulatory Compliance:

• The report is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating compliance with U.S. securities regulations for foreign private issuers.

This summary encapsulates the essential details regarding the filing, the company, and the compliance aspects relevant to investors and analysts following Quantum BioPharma Ltd.